BBVA
GSK icon

Banco Bilbao Vizcaya Argentaria’s GSK GSK Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
219,939
-130,963
-37% -$6.93M 0.07% 187
2026
Q1 		$19.4M Buy
350,902
+346,095
+7,200% +$18.8M 0.14% 123
2025
Q4 		$236K Sell
4,807
-172
-3% -$8.02K ﹤0.01% 692
2025
Q3 		$215K Buy
+4,979
New +$194K ﹤0.01% 716
2025
Q2 		– Sell
-5,362
Closed -$208K – 710
2025
Q1 		$208K Buy
+5,362
New +$196K ﹤0.01% 709
2024
Q4 		– Sell
-5,787
Closed -$237K – 699
2024
Q3 		$237K Hold
5,787
– – ﹤0.01% 691
2024
Q2 		$223K Sell
5,787
-408
-7% -$17.2K ﹤0.01% 707
2024
Q1 		$266K Sell
6,195
-1,670
-21% -$68.9K ﹤0.01% 726
2023
Q4 		$291K Sell
7,865
-600
-7% -$21.5K ﹤0.01% 694
2023
Q3 		$307K Sell
8,465
-382
-4% -$13.6K ﹤0.01% 679
2023
Q2 		$315K Buy
8,847
+1,800
+26% +$64.6K ﹤0.01% 666
2023
Q1 		$251K Sell
7,047
-590
-8% -$20.6K ﹤0.01% 684
2022
Q4 		$268K Hold
7,637
– – ﹤0.01% 671
2022
Q3 		$225K Buy
+7,637
New +$289K ﹤0.01% 694
2022
Q2 		– Sell
-9,607
Closed -$530K – 707
2022
Q1 		$530K Sell
9,607
-667
-6% -$36.2K 0.01% 583
2021
Q4 		$567K Sell
10,274
-7,416
-42% -$386K 0.01% 644
2021
Q3 		$846K Buy
17,690
+1,622
+10% +$81.5K 0.01% 530
2021
Q2 		$799K Buy
16,068
+9,548
+146% +$459K 0.01% 555
2021
Q1 		$294K Sell
6,520
-1,520
-19% -$69K 0.01% 683
2020
Q4 		$369K Buy
8,040
+2,400
+43% +$110K 0.01% 612
2020
Q3 		$265K Buy
+5,640
New +$283K 0.01% 612

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's GSK Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its GSK (GSK) stake by 37% in Q2 2026, selling an estimated $6.93M and leaving 219,939 shares worth $11.5M. The position accounts for 0.07% of the portfolio, ranked #187.

Banco Bilbao Vizcaya Argentaria first reported a position in GSK in Q3 2020 and has held it in 21 quarters since. The position peaked at $19.4M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 219,939 shares of GSK worth $11.5M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 130,963 GSK shares in Q2 2026, an estimated $6.93M.
  • GSK made up 0.07% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #187 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in GSK in Q3 2020 and has held it in 21 quarters since.
  • Banco Bilbao Vizcaya Argentaria's GSK position peaked at $19.4M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.